These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9294507)

  • 1. Combination assay for tumor markers in oral squamous cell carcinoma.
    Kurokawa H; Yamashita Y; Tokudome S; Kajiyama M
    J Oral Maxillofac Surg; 1997 Sep; 55(9):964-6. PubMed ID: 9294507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of tumor markers in patients with squamous cell carcinoma in the oral cavity.
    Kurokawa H; Tsuru S; Okada M; Nakamura T; Kajiyama M
    Int J Oral Maxillofac Surg; 1993 Feb; 22(1):35-8. PubMed ID: 7681461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYFRA 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumor marker in non-small cell lung cancer.
    Lai RS; Hsu HK; Lu JY; Ger LP; Lai NS
    Chest; 1996 Apr; 109(4):995-1000. PubMed ID: 8635383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
    Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P
    J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum SCCA, Cyfra 21-1, EGFR and Cyclin D1 levels in patients with oral squamous cell carcinoma.
    Feng XY; Li JH; Li JZ; Han ZX; Xing RD
    Int J Biol Markers; 2010; 25(2):93-8. PubMed ID: 20586028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYFRA 21-1 is a useful marker for esophageal squamous cell carcinoma.
    Yamamoto K; Oka M; Hayashi H; Tangoku A; Gondo T; Suzuki T
    Cancer; 1997 May; 79(9):1647-55. PubMed ID: 9128978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
    Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of tumor markers in patients with squamous cell carcinoma of the head and neck.
    Ogawa T; Tsurusako Y; Kimura N; Nishioka S; Akagi H; Nishizaki K; Nishioka K; Rutka J
    Acta Otolaryngol Suppl; 1999; 540():72-6. PubMed ID: 10445084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High levels of cytokeratin 19 fragments but no evidence of cytokeratins 1, 2, 10/11, 14 or filaggrin in the serum of squamous cell lung carcinoma patients.
    Miédougé M; Devys A; Simon M; Rouzaud P; Salama G; Reyre J; Pujazon M; Carles P; Serre G
    Tumour Biol; 2001; 22(1):19-26. PubMed ID: 11054023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CYFRA 21-1: a new marker of epidermoid cancer of the bronchi. Comparison with 3 other markers].
    Pujol JL; Grenier J; Ray P; Gautier V; Aouta MD; Michel FB
    Presse Med; 1993 Jun; 22(22):1039-42. PubMed ID: 7692432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCCA, TSGF, and the Long Non-Coding RNA AC007271.3 are Effective Biomarkers for Diagnosing Oral Squamous Cell Carcinoma.
    Shao T; Huang J; Zheng Z; Wu Q; Liu T; Lv X
    Cell Physiol Biochem; 2018; 47(1):26-38. PubMed ID: 29763905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis in bronchogenic squamous cell carcinoma groups divided according to serum squamous cell carcinoma-related antigen and cytokeratin 19 fragment levels.
    Kashiwabara K; Nakamura H; Esaki T
    Clin Chim Acta; 2000 Apr; 294(1-2):105-13. PubMed ID: 10727677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of a new tumour marker, CYFRA 21-1, in squamous cell carcinoma of the head and neck, and comparison with squamous cell carcinoma antigen.
    Yen TC; Lin WY; Kao CH; Cheng KY; Wang SJ
    Clin Otolaryngol Allied Sci; 1998 Feb; 23(1):82-6. PubMed ID: 9563673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of serum HMGB1 levels in early detection of recurrent squamous cell carcinoma of uterine cervix: comparison with serum SCCA, CYFRA21-1, and CEA levels.
    Sheng X; Du X; Zhang X; Li D; Lu C; Li Q; Ma Z; Song Q; Wang C
    Croat Med J; 2009 Oct; 50(5):455-64. PubMed ID: 19839069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of serum CYFRA 21-1 in lung cancer.
    Muraki M; Tohda Y; Iwanaga T; Uejima H; Nagasaka Y; Nakajima S
    Cancer; 1996 Apr; 77(7):1274-7. PubMed ID: 8608502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
    Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
    Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of the SCC, CEA, CYFRA 21.1, and CRP markers for the diagnosis and monitoring of cervical squamous cell carcinoma].
    Chmura A; Wojcieszek A; Mrochem J; Walaszek-Gruszka A; Deja R; Masłyk B; Bartnik W; Sodowski K
    Ginekol Pol; 2009 May; 80(5):361-6. PubMed ID: 19548456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of a panel of tumor markers as prognostic factors in patients with squamous cell carcinoma of head and neck.
    Kandiloros D; Eleftheriadou A; Chalastras T; Kyriou L; Yiotakis I; Ferekidis E
    Med Oncol; 2006; 23(4):463-70. PubMed ID: 17303904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of CYFRA 21-1 and squamous cell carcinoma antigen in detecting nasopharyngeal carcinoma.
    Lee JK; Hsieh JF; Tsai SC; Ho YJ; Sun SS; Kao CH
    Ann Otol Rhinol Laryngol; 2001 Aug; 110(8):775-8. PubMed ID: 11510737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokeratin subunit 19 measured by CYFRA 21-1 assay in follow-up of cervical cancer.
    Kainz C; Sliutz G; Mustafa G; Bieglmayr C; Koelbl H; Reinthaller A; Gitsch G
    Gynecol Oncol; 1995 Mar; 56(3):402-5. PubMed ID: 7535720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.